Clinical Guides
Community-Acquired Pneumonia
A source-grounded guide to recognising, confirming and treating community-acquired pneumonia, with severity, sepsis, tuberculosis and antimicrobial-resistance safeguards for Indian practice.
MedNext Academy | 13 min read
Community-Acquired Pneumonia
A source-grounded guide to recognising, confirming and treating community-acquired pneumonia, with severity, sepsis, tuberculosis and antimicrobial-resistance safeguards for Indian practice.
Summary
Community-acquired pneumonia (CAP) is an acute infection of lung parenchyma acquired outside hospital or sufficiently early in a hospital attendance that it is not classified as hospital-acquired infection. It is a clinical syndrome rather than a single-organism diagnosis. Bacteria and respiratory viruses can produce overlapping presentations, and coinfection occurs. Cough, fever, sputum, breathlessness, pleuritic pain, hypoxaemia, tachypnoea or focal chest signs increase probability, but older or immunocompromised patients may present with confusion, weakness or functional decline instead of classic symptoms.
The first priorities are physiological severity, sepsis and respiratory failure. Record oxygen saturation, respiratory rate, blood pressure, mental state and ability to drink; obtain urgent senior or emergency support when instability is present. A validated score such as CRB65 or CURB65 can support adult disposition, but never overrides clinical judgement, oxygen need, comorbidity, pregnancy, social safety or rapid deterioration. Hospital diagnosis usually includes timely chest imaging. Microbiological tests are selective: low-severity disease rarely benefits from routine broad testing, whereas severe, unusual, non-responding or resistance-risk presentations do.
Antibiotic choice must follow current local policy, severity, recent antibiotics, allergy, renal or hepatic function, pregnancy, likely pathogens and local resistance. Start promptly once bacterial CAP is diagnosed; suspected sepsis follows an emergency sepsis pathway. Review intravenous therapy and microbiology early, narrow when possible, and avoid unnecessary prolonged or broad-spectrum exposure. In India, tuberculosis, aspiration and prior healthcare exposure require deliberate assessment. This guide is a quarantined educational draft, not a prescribing protocol.
How Common Is It?
CAP is common across the life course and contributes substantially to outpatient consultations, admission, critical illness and death. Incidence and outcome rise with age, frailty, chronic disease and impaired immunity. current guidelines' 2025 context cites an annual adult incidence of roughly five to ten per thousand and substantial hospital use in the United Kingdom, but those are UK estimates and must not be relabelled as Indian rates. Case definitions, access to imaging, age distribution and surveillance methods differ between countries.
Indian burden cannot be represented honestly by one number in this guide. Surveillance may combine bacterial pneumonia, viral pneumonia, severe acute respiratory infection or all lower-respiratory infection, while many community cases are treated without organism confirmation. Childhood pneumonia trends also reflect vaccination, nutrition and care access and should not be extrapolated to adults. Geographic, seasonal and outbreak variation matters, particularly for influenza and other respiratory viruses.
The practical epidemiology is individual risk and local circulation. Severe outcomes are more likely in older adults, infants, people with chronic cardiopulmonary disease, diabetes, renal or liver disease, neurological swallowing problems, immunosuppression, harmful alcohol use, malnutrition or previous splenectomy. Delayed presentation, limited oxygen access and inability to obtain or complete treatment can worsen outcome. The most useful service measures are time to physiological assessment, oxygen when indicated, appropriate antibiotic initiation, early review, microbiological yield in selected patients, safe discharge and readmission. This draft avoids unsupported rankings, pathogen percentages or claims that one organism pattern applies uniformly across India.
Risk Factors
Age at either extreme, frailty and chronic lung disease increase susceptibility and reduce physiological reserve. Other important factors include heart failure, diabetes, chronic kidney or liver disease, malignancy, HIV, immunosuppressive treatment, asplenia, malnutrition, smoking and harmful alcohol use. Prior influenza or another viral respiratory infection can precede bacterial pneumonia. Poor dentition, impaired consciousness, dysphagia, stroke, neuromuscular disease, reflux and tube feeding increase aspiration risk. Ask about choking and dependent-lobe disease rather than assuming every infiltrate is ordinary CAP.
Recent hospitalisation, residence in a healthcare facility, prior antibiotics, known colonisation and repeated healthcare exposure alter resistance risk. They do not automatically justify the broadest antibiotic; they justify careful classification, cultures where useful and locally informed empiric therapy. Structural lung disease such as bronchiectasis, previous tuberculosis cavities or severe COPD changes likely pathogens. Travel, hotel or cooling-water exposure, animal contact and outbreak links may suggest specific causes.
Environmental and access factors matter in India. Household crowding, tobacco smoke, biomass exposure and ambient air pollution can increase respiratory vulnerability, while distance from care or absence of pulse oximetry can delay recognition of hypoxaemia. Incomplete vaccination increases risk from preventable respiratory pathogens, but vaccine schedules vary by age, condition and programme.
For deterioration, focus on current physiology: increasing respiratory rate, oxygen requirement, hypotension, confusion, oliguria, rising lactate where measured, multilobar involvement and inability to maintain oral intake. A low numerical score does not erase a dangerous trajectory, immunosuppression, pregnancy or unsafe home circumstances.
Diagnosis
CAP diagnosis integrates syndrome, physiological assessment and imaging where indicated; treatment must not wait for a perfect organism label in an unstable patient.
History
Clarify onset and progression of cough, sputum, fever, rigors, breathlessness, pleuritic pain, haemoptysis, confusion and oral intake. Ask about viral prodrome, contacts, travel, aspiration or vomiting, seizures, swallowing difficulty, recent hospitalisation, antibiotics, colonisation, tuberculosis exposure, weight loss and night sweats. Record cardiopulmonary disease, diabetes, renal or liver dysfunction, HIV or immunosuppression, pregnancy, vaccination, allergies and current medicines. Establish baseline function and oxygen requirement.
Examination
Perform an ABCDE assessment when ill. Measure respiratory rate accurately, oxygen saturation, heart rate, blood pressure, temperature, mental state and perfusion. Assess work of breathing, speech, cyanosis and hydration. Chest findings may include focal crackles, bronchial breathing, dullness or reduced air entry, but absence does not exclude pneumonia. Look for effusion, cardiac failure, deep-vein thrombosis, rash, meningism and aspiration clues. Calculate CRB65 or CURB65 in appropriate adults only after measurements are reliable; interpret alongside clinical and social factors.
Investigations
In hospital, obtain chest radiography promptly; lung ultrasound can assist trained clinicians, especially in deterioration, alternative heart failure or pleural disease. Blood count, renal and liver tests, electrolytes, glucose, inflammatory markers, lactate, blood gas and ECG are selected by severity and treatment needs. Current guidelines advises against routine microbiology for low-severity adult CAP or non-severe childhood CAP. Consider blood and good-quality sputum cultures, pneumococcal or Legionella urine antigen and viral testing in moderate, severe, epidemiologically relevant or non-responding disease. Pursue molecular TB testing when clinical or radiological features warrant it.
Differential Diagnosis
Acute bronchitis and uncomplicated viral upper-respiratory infection cause cough without convincing parenchymal disease. Influenza, COVID-19, RSV and other viral infections can cause either isolated upper-airway symptoms or viral pneumonia; testing is guided by circulation, vulnerability and treatment or infection-control consequences. An asthma or COPD exacerbation favours wheeze and variable obstruction, but infection may coexist. Heart failure can cause bilateral crackles, oedema and radiographic opacities; ultrasound, natriuretic peptides and cardiac assessment may help when the picture is mixed.
Pulmonary embolism can produce pleuritic pain, tachycardia, hypoxaemia, haemoptysis and even fever, sometimes with a nonspecific opacity. Pneumothorax, acute coronary syndrome and pericarditis are other dangerous chest-pain or breathlessness mimics. Aspiration pneumonitis after a witnessed large-volume aspiration is chemical injury and does not automatically require antibiotics, whereas aspiration pneumonia is infection associated with aspiration risk; chronology, distribution and subsequent course matter.
In India, pulmonary tuberculosis is a mandatory alternative when symptoms are prolonged, weight loss or night sweats occur, exposure is known, imaging is upper-lobe, cavitating or otherwise suspicious, or apparent pneumonia fails to resolve. Fluoroquinolone exposure before TB testing can transiently mask disease and select resistance, so indiscriminate use is unsafe. Melioidosis, scrub typhus, leptospirosis, fungal infection and opportunistic infection enter the differential according to geography, exposure and immune status.
Lung cancer or an obstructing lesion can cause post-obstructive pneumonia, especially with recurrent same-site disease or persistent radiographic abnormality. Vasculitis, organising pneumonia, eosinophilic lung disease, alveolar haemorrhage and drug pneumonitis should be considered when antibiotics fail and the syndrome is atypical.
Management
Stabilise before refining aetiology. Use an ABCDE approach, secure monitoring and intravenous access when indicated, and activate a sepsis pathway for suspected sepsis or shock. Give oxygen for hypoxaemia to an individualised target, recognising risk of hypercapnic respiratory failure in some chronic lung disease. Escalate respiratory support when work of breathing or oxygenation worsens; do not allow a severity score to delay critical care review. Treat hypoglycaemia, dehydration and other reversible problems cautiously, avoiding indiscriminate fluid loading in heart or renal failure.
Decide place of care using physiology, CRB65/CURB65 where applicable, comorbidity, imaging, oral intake, pregnancy, frailty, social support and access to review. Home treatment requires reliable medicines, understanding of warning signs and timely follow-up. In bacterial CAP, begin empiric antibiotic treatment promptly according to current local guidance. Current guidelines recommends treatment within four hours of hospital presentation after diagnosis; suspected sepsis requires the relevant emergency timing rather than routine scheduling.
Supportive care includes analgesia or antipyresis when safe, hydration, nutrition, mobilisation and venous-thromboembolism assessment in admitted patients. Routine cough suppression is not a substitute for monitoring. Investigate and drain a clinically significant complicated parapneumonic effusion or empyema with specialist input.
Reassess clinical response, oxygen need, cultures and diagnosis. Review intravenous antibiotics by about forty-eight hours and switch to oral therapy when stable and able to absorb. Narrow treatment when microbiology permits. Lack of improvement prompts checks of adherence, resistance, complication, aspiration, TB, obstruction and a non-infectious mimic rather than automatic antibiotic stacking.
Prescribing Information
This educational draft intentionally does not reproduce a universal antibiotic table. Before prescribing, verify age, weight, allergy phenotype, pregnancy or breastfeeding, renal and hepatic function, QT risk, interactions, recent antibiotics, prior cultures, aspiration risk and local susceptibility data. The 2025 Indian national guideline provides syndrome-level regimens, while each institution should adapt them to its antibiogram and formulary. current guidelines is a current international comparator but UK choices cannot be transplanted automatically into Indian resistance ecology.
Use the narrowest empiric regimen that adequately covers the severity and credible pathogens. Oral therapy is preferred when the patient can take and absorb it and severity does not require intravenous treatment. Reserve antipseudomonal, anti-MRSA and carbapenem therapy for validated risk or microbiological evidence, not anxiety alone. Obtain cultures before antibiotics when useful and when this does not delay urgent treatment. Document indication, start time, planned duration and review point.
For adults, current guidelines recommends stopping at five days when clinically stable unless microbiology or instability justifies longer treatment. Apply duration through the governing local guideline and patient response, especially in children, abscess, empyema, Staphylococcus aureus, Legionella, TB or other diagnoses requiring different courses. Review intravenous treatment by forty-eight hours and de-escalate.
Check class-specific harms: immediate or delayed allergy, diarrhoea and Clostridioides difficile, renal or hepatic injury, QT prolongation, cytopenia, tendon or neurological toxicity and drug interactions. Avoid routine fluoroquinolone use where TB is plausible. Antibiotics do not replace oxygen, drainage, sepsis care or source control, and clinical improvement never validates an initially unsupported organism claim.
When to Refer
Emergency transfer or hospital care is required for severe respiratory distress, significant hypoxaemia, cyanosis, shock, altered consciousness, rapidly increasing oxygen need, inability to protect the airway, suspected sepsis, or need for ventilatory support. Provide oxygen and resuscitative care during transfer according to competence and protocol. Early critical-care discussion is appropriate for escalating oxygen requirements, severe acidosis, exhaustion, vasopressor need, multilobar disease or deteriorating physiology.
Admission thresholds should be lowered for frailty, pregnancy, major cardiopulmonary or renal disease, immunosuppression, poor oral intake, unreliable home observation, failed outpatient treatment or significant complication. CRB65 and CURB65 support adult decisions but do not incorporate every risk. Children require age-specific severity assessment rather than adult scores. A patient who cannot obtain medicines or return for review is not safely managed at home simply because a score is low.
Refer respiratory or infectious-disease expertise for uncertain diagnosis, unusual exposure, recurrent or non-resolving pneumonia, suspected resistant pathogen, severe immunosuppression, cavitation, lung abscess, empyema, bronchiectasis or possible TB. Pleural infection needs timely ultrasound, sampling and drainage decisions. Repeated same-lobe infection or persistent collapse requires evaluation for obstruction or foreign body.
Arrange follow-up based on recovery and risk. Current guidelines advises not to offer a routine six-week chest radiograph to everyone discharged after pneumonia; consider it when symptoms persist or worsen, or when lung cancer or underlying respiratory disease risk exists, including smoking or age over fifty. Persistent TB-compatible symptoms require an NTEP-aligned diagnostic pathway, not repeated empirical antibiotics.
Red Flags
Immediate threats are severe hypoxaemia, rapidly rising oxygen requirement, cyanosis, marked work of breathing, exhaustion, reduced consciousness, hypotension, cold peripheries, oliguria, severe acidosis or lactate elevation where assessed. Respiratory rate is a vital sign, not a documentation formality. A patient who is tiring may breathe more slowly while deteriorating. Silent or minimal chest signs do not reassure when physiology is abnormal. Activate sepsis and critical-care pathways early.
Complications should be suspected with persistent fever, ongoing sepsis, pleuritic pain or failure to improve. A growing or loculated effusion suggests complicated parapneumonic effusion or empyema. Cavitation raises abscess, necrotising infection, tuberculosis, malignancy or selected pathogens. Sudden deterioration can indicate pulmonary embolism, pneumothorax, acute respiratory distress syndrome, myocardial injury or arrhythmia. Haemoptysis ranges from minor inflammation to a life-threatening bleed and requires severity-based assessment.
Diagnostic red flags include prolonged constitutional symptoms, TB contact, upper-lobe or cavitating disease, recurrent opacity in the same location, unexplained lymphadenopathy, clubbing, weight loss or persistent radiographic change. Aspiration risk, seizures or reduced consciousness may redirect treatment and prevention. Immunocompromised patients can have muted fever or inflammatory markers despite severe infection.
At discharge, urgent return triggers include worsening breathlessness, new confusion, fainting, blue colour, inability to drink, reduced urine, persistent vomiting, chest pain, haemoptysis, recurrent fever after improvement or failure to follow the agreed recovery trajectory. Written safety-net instructions should specify a reachable service and account for distance, language and caregiver support.
Indian Clinical Context
The Government of India National Treatment Guidelines for Antimicrobial Use in Infectious Disease Syndromes, Version 2.0, dated November 2025, is the national stewardship anchor for this guide. It lists CAP organisms and syndrome-based empiric options, but explicitly functions as a framework that institutions must align with their microbiology and antibiograms. Indian resistance is heterogeneous. Prior antibiotics, recent healthcare exposure and local culture history should shape decisions; broad treatment without risk evidence accelerates resistance and can harm the patient.
Tuberculosis must be considered deliberately, not only after many failed antibiotic courses. Chronic or recurrent symptoms, weight loss, night sweats, exposure, haemoptysis, suspicious imaging or slow resolution should prompt appropriate respiratory sampling and WHO-recommended rapid molecular testing through the applicable NTEP pathway. Fluoroquinolone monotherapy can partially suppress TB and delay diagnosis, so it is a poor reflex choice when TB is plausible. Aspiration, post-TB structural lung disease and bronchiectasis also change the differential and likely microbiology.
Access to imaging, microbiology, oxygen and critical care varies. When pulse oximetry is available, interpret it with the clinical picture and recognise potential measurement inaccuracy, including with poor perfusion and across skin pigmentation. Where resources are limited, careful serial respiratory rate, mental state, blood pressure, work of breathing and perfusion become even more important; lack of a test must not become false reassurance.
Review vaccination against the current Universal Immunisation Programme for children and current risk-based recommendations for adults, including influenza and pneumococcal vaccination where indicated. Address smoking, biomass exposure, nutrition, swallowing risk and medicine access without promising that any single intervention prevents all pneumonia.
NMC Competency Mapping
Use the official NMC CBME Curriculum 2024 tables for formal competency codes rather than copying unverified legacy labels. CAP supports integrated Internal Medicine competencies in evaluating fever, cough, breathlessness, hypoxaemia and sepsis; Paediatrics competencies in age-specific respiratory assessment; Microbiology competencies in respiratory specimen selection, interpretation and antimicrobial susceptibility; Pharmacology competencies in rational antimicrobial selection and adverse-effect monitoring; Radiodiagnosis competencies in choosing and interpreting chest imaging; and Community Medicine competencies in vaccination, surveillance and antimicrobial resistance.
A learner should obtain a severity-focused history, perform accurate vital-sign and respiratory assessment, recognise sepsis, calculate an adult severity score appropriately and explain its limits. They should interpret consolidation, effusion and alternative radiographic patterns, identify when microbiology is useful, and distinguish CAP from viral infection, pulmonary embolism, heart failure, aspiration and TB. They should not diagnose a pathogen from sputum colour or a traditional eponym alone.
Management skills include oxygen selection and monitoring, safe fluid assessment, timely locally guided antibiotics, culture review, intravenous-to-oral switch, de-escalation, complication recognition and discharge safety-netting. Professional competence includes documenting allergy details, indication, review date and uncertainties; communicating with patients and families; and escalating beyond one's competence. An OSCE can test a deteriorating pneumonia assessment or antimicrobial review. This educational mapping does not authorise independent prescribing and does not change the draft's awaiting-review status.
Key Exam Pearls for NEET PG
CAP is parenchymal infection acquired in the community, diagnosed from a compatible acute syndrome with imaging support in hospital. Streptococcus pneumoniae remains a classic common bacterial cause, but examination questions should not imply that sputum appearance identifies an organism. Respiratory viruses, atypical bacteria and coinfection are possible. Older adults may present with confusion or functional decline. Tachypnoea, hypoxaemia, hypotension and altered mental state are high-yield severity findings.
CRB65 uses confusion, respiratory rate at least thirty, low blood pressure and age at least sixty-five; CURB65 adds urea above seven mmol/L. Scores inform mortality risk and disposition in adults but do not replace judgement. A low score can coexist with hypoxaemia, serious comorbidity, pregnancy, immunosuppression or unsafe home care. Children require paediatric criteria. Hospital CAP usually warrants timely chest radiography; routine microbiological tests are not needed in low-severity disease, while selected tests matter in moderate, severe or unusual presentations.
Start locally appropriate antibiotics promptly after bacterial CAP diagnosis, and use an emergency sepsis pathway when indicated. Prefer oral therapy if severity permits, review intravenous treatment at forty-eight hours, narrow from cultures and avoid unnecessary broad or long courses. Empyema requires drainage plus antimicrobial care. Non-response prompts TB, aspiration, resistance, abscess, obstruction and mimics. Follow-up radiography is targeted, not automatic for every recovered patient. In India, TB assessment and local resistance data are central safety principles.
Frequently Asked Questions
Can a person with community-acquired pneumonia be treated safely at home?
Some clinically stable patients with low-severity disease can be treated at home, but the decision includes oxygen saturation, respiratory rate, blood pressure, mental state, comorbidity, oral intake, pregnancy, social support and access to review. CRB65 can assist adult assessment but cannot make the decision alone. Worsening symptoms require urgent reassessment.
Why are sputum and blood cultures not performed for every pneumonia?
Routine microbiology has low yield and often does not change care in low-severity CAP. It becomes more useful in moderate or severe disease, suspected sepsis, prior antibiotics, unusual exposure, resistance risk, non-response or immunosuppression. A good-quality specimen and a clear plan to act on the result are more valuable than indiscriminate testing.
When should tuberculosis be considered instead of routine bacterial pneumonia in India?
Consider TB with prolonged cough, weight loss, night sweats, haemoptysis, TB exposure, upper-lobe or cavitating imaging, recurrent illness or failure to recover as expected. Use the applicable NTEP pathway and WHO-recommended molecular diagnostics. Repeated empirical antibiotics, especially fluoroquinolones, can delay recognition and contribute to resistance.
Does everyone need a chest X-ray six weeks after pneumonia?
No. Current current guidelines guidance advises against routine six-week radiography for every person discharged after pneumonia. Consider follow-up imaging when symptoms persist or worsen or when underlying lung disease or cancer risk exists, including smoking or age over fifty. Local policy and the original radiographic pattern also inform the plan.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic